CFN Media Releases Exclusive Video Series: Dr. Sue Sisley Unlocks Medical Marijuana Efficacy thru Science & Cultivation
April 6th, 2017
News, Top News
Renowned medical marijuana research scientist Dr. Sue Sisley has pioneered research on the efficacy of medical cannabis as an effective treatment option for veterans suffering from chronic post-traumatic stress disorder (PTSD). In 2014, she secured a rare approval from the federal government to study the effects of marijuana on PTSD.
In 2015, Heliospectra AB (OTCQB: HLSPY) (FIRSTNORTH: HELIO), a world leader in intelligent lighting technology for greenhouse cultivation and plant research, hired Dr. Sue Sisley as its Director of Medical Plant Research. Dr. Sisley and Heliospectra are working with cannabis growers to develop scalable medicinal cultivation methodologies while overseeing data collection and reporting with the company’s medicinal cannabis growers in the U.S., Canada, and around the world.
Heliospectra has enabled Dr. Sisley to continue this groundbreaking research where she plans to publish all results – good or bad – to foster a better understanding of the plant and the transformative effect it can have on patients.
In this video series produced by CFN Media, Dr. Sisley outlines her research ambitions and the potential impact the studies could have on patients while highlighting why Heliospectra’s lighting solutions represent a key breakthrough in the cultivation of medical cannabis.
A Bright Future:
The Science of Medicine and Plants:
Kindred Spirits – Delivering Consistent, Quality Product:
Standardized Medicine – Predictable Results:
Heliospectra AB (OTCQB: HLSPY) (FIRSTNORTH: HELIO) was founded in 2006 and is the industry’s most proven intelligent lighting technology for greenhouse and controlled plant growth environments, with the vision to make commercial crop production more connected and resource-efficient. Growers and commercial producers across six continents use Heliospectra’s holistic and flexible solutions to consistently increase yields while producing crops that achieve quality appearance, superior nutritional or medicinal value and longer shelf life, harvest after harvest. Winner of multiple international awards and recognitions, Heliospectra has raised more than $32 million in capital to date.
Follow Us on Social Media
About CFN Media
CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.
CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.
Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.